Zavala, Eleonor
Mohan, Diwakar
Ali, Hasmot
Siddiqua, Towfida J.
Haque, Rezwanul
Ayesha, Kaniz
Ahsan, Khalid Bin
Sujan, Hasan Mahmud
Khaled, Nazrana
Rahman, Atiya
Chakraborty, Barnali
Dyer, Brian
Wu, Lee S. F.
Kalbarczyk, Anna
Erchick, Daniel J.
Thorne-Lyman, Andrew L.
Tumilowicz, Alison
Afsana, Kaosar
Christian, Parul
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-033381)
Article History
Received: 16 February 2024
Accepted: 23 April 2024
First Online: 13 May 2024
Declarations
:
: TARGET-BEP has been approved by the BRAC James P. Grant School of Public Health Institutional Review Board (FWA00029561) at BRAC University in Bangladesh and the Bloomberg School of Public Health IRB (FWA00000287) at Johns Hopkins University in Baltimore, Maryland. Written, informed consent to participate will be obtained from all participants. Important protocol modifications will be communicated to the IRBs and reported on ClinicalTrials.gov.
: No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Model informed consent forms are available upon request to the corresponding author.
: The authors declare that they have no competing interests.